Business Health Industry News

Global Stem Cell Market is expected to reach US$ 14.93 billion by 2022

Press Release

By 2022, the Global Stem Cell Market is estimated to reach US$ 14.93 billion, up from US$ 9.89 billion in 2016, growing at a CAGR of 8.6% during the forecast period. A stem cell is an undifferentiated biological cell that has the potential to develop into specialized cell types in the body. Given their unique regenerative abilities, stem cells offer prospective treatments for neurodegenerative diseases and conditions such as diabetes, heart diseases, and brain injuries. The most widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system. In addition to enabling regenerative medicine, stem cell research also promises to enhance drug discovery and development. Important clinical trials are underway and researches continue to explore new avenues for using stem cells in medicine.

Request For Free Sample @

The end-users of the stem cell market are hospitals, cell banks, clinical research laboratories, and academic institutes.

Market Dynamics
The global stem cell market is one of the most promising markets in the field of medicine and is expected to grow even more in the forecast period as stem cells enable cost-effective treatment of many conditions that currently have poor or no treatment. To address the increasing demand for stem cell banking services and regenerative treatment, scientists are engaged in discovering novels methods to produce human stem cells. Factors such as growing awareness related to the therapeutic potential of stem cells in disease management, increase in the patient population, rising investments in research and government support are expected to further accelerate the development of regenerative medicine, thus driving the market growth.
Whilethe market has ample scope for growth, factors such as high cost, regulatory policies, and ethical framework restrain it as well. Moreover, the list of diseases for which stem cell treatment has been proven safe and effective is still very short. Despite these hurdles, stem cell therapy is believed to be the next major advancement in transforming healthcare.

Market Segmentation
The globalstem cellmarket is fragmented on the basis of cell type, therapeutic application, and technology.

Cell Type
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Rat Neural Stem Cells
Therapeutic Application
Musculoskeletal Disorders
Wounds and Injuries
Cardiovascular Diseases
Gastrointestinal diseases
Stem Cell Acquisition
Stem Cell Production
Stem Cell Cryopreservation
Stem Cell Expansion
Geographical Analysis

The North American region is by far the largest stakeholder in the global stem cell market and is expected to continue its dominance across the globe. The European Market, segmented into the United Kingdom, Germany, France, Italy, Spain, and rest of Europe, is the second leading market for stem cells. However, due to increasing awareness among the public and advances in technology, the market in Asia-Pacific is expected to grow at a high rate.

Buy This Premium Report Now @

Key Players
Companies like Osiris Therapeutics Inc. (U.S.), NuVasive Inc. (U.S.), AlloSource (U.S.), RTI Surgical, Inc. (U.S.), Medipost Co. Ltd. (South Korea), Anterogen Co. Ltd. (South Korea), Pharmicell Co. Ltd. (South Korea), HolostemTerapieAvanzate(Italy), and JCR Pharmaceuticals Co. Ltd. (Japan) are some of the key players operating in the global stem cell therapy market.
Report Contents Regional Analysis Report Highlights

Market segments
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis

Strategic and Critical Success Factor Analysis of Key Players

North America
US and Canada
Latin America
Mexico, Brazil, Argentina and Rest of Latin America
Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Eastern Europe
Rest of Eastern Europe
Asia Pacific
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
Market Segmentation
Estimated Market Sizing in terms of volume and value
Recent trends in Market and impact
Research Status and Technology Overview
Extensive Industry Structure Coverage

Read More @

About Kenneth Research:

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.

Contact Us

Name:  David

Email: [email protected]

Phone: +1 313 462 0609